"10.1371_journal.pone.0069354","plos one","2013-07-19T00:00:00Z","Kuan-Chung Hsiao; Neng-Yao Shih; Hsun-Lang Fang; Tze-Sing Huang; Ching-Chuan Kuo; Pei-Yi Chu; Yi-Mei Hung; Shao-Wen Chou; Yi-Yuan Yang; Gee-Chen Chang; Ko-Jiunn Liu","Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Cosmetology and Health Care, Min-Hwei College of Health Care Management, Tainan, Taiwan; Department of Pathology, St. Martin De Porres Hospital, Chiayi, Taiwan; School of Medical Laboratory Science and Biotechnology, Taipei Medical University, Taipei, Taiwan; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Institute of Biomedical Sciences, National Chung-Hsing University, Taichung, Taiwan; School of Medicine, China Medical University, Taichung, Taiwan","Conceived and designed the experiments: KH GC KL. Performed the experiments: KH NS HF TH CK YH SC. Analyzed the data: KH PC KL. Contributed reagents/materials/analysis tools: YY. Wrote the paper: KH GC KL.","The authors declare that G.C. Chang, N.Y. Shih and K.J. Liu hold a US and Taiwanese patents. Patent name: alpha-enolase specific antibody and method of use. Patent number: US7645453B2 and I30444. There are no further patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Kuan-Chung Hsiao","KCH",11,TRUE,3,7,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
